The Canada Microbiology Testing Market was valued at $297.5 Million in 2025 and projected to reach to $368.3 Million by 2030, representing a compound annual growth rate of 3.7%. Canada's microbiology testing market demonstrates stable growth driven by the country's well-established healthcare system and continuous investment in diagnostic capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada's microbiology testing market is valued at $297.5 million in 2025 and is projected to reach $368.3 million by 2030, representing a steady CAGR of 3.7% over the forecast period.
Canada's robust publicly-funded healthcare system and advanced diagnostic infrastructure drive consistent demand for microbiology testing across clinical laboratories, hospitals, and diagnostic centers nationwide.
Key growth factors include increasing prevalence of infectious diseases, rising demand for rapid diagnostic testing, healthcare modernization initiatives, and expanded laboratory automation across Canadian healthcare facilities.
Canada's 3.7% CAGR is moderate compared to the global market's 5.3%, reflecting a mature healthcare market with steady, predictable growth patterns and established diagnostic testing protocols.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | VIRAL (Pathogen Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.3% from 2025 to 2030 |
| Largest Segment | TRADITIONAL MICROBIOLOGY METHODS (TMM) (Technology Type) |
| Market Size Base Year (Billions) | ~USD 7.4 (2025) |
| Revenue Forecast (Billions) | ~USD 9.58 (2030) |
| Segments Covered | Product, Type, Technology Type, Pathogen Type, End User, Technology, End Users |
7 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| COSMETICS & PERSONAL CARE COMPANIES | 17.5 | 17.9 | 18.2 | 18.6 | 19 | 19.5 | 20 | 20.6 | 2.5 |
| ENVIRONMENTAL & WATER TESTING | 42.9 | 44.3 | 45.8 | 47.4 | 49.1 | 51 | 53 | 55.2 | 3.8 |
| FOOD & BEVERAGE COMPANIES | 54.6 | 55.9 | 57.3 | 58.8 | 60.5 | 62.3 | 64.3 | 66.4 | 3 |
| OTHER END USERS | 11.4 | 11.6 | 11.8 | 12 | 12.2 | 12.4 | 12.7 | 13 | 2 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 162 | 167.8 | 174 | 180.6 | 187.8 | 195.6 | 204.1 | 213.2 | 4.2 |
| TOTAL | 288.5 | 297.5 | 307.1 | 317.4 | 328.6 | 340.8 | 354 | 368.3 | 3.7 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMÉRIEUX | France | Public Company | Syndromic and low-plex PCR (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE),Microbiology ID/AST and blood culture (VITEK 2, VITEK MS, VITEK REVEAL, BACT/ALERT, ETEST, API),Immunoassays and sepsis markers (VIDAS, Hybiome CLIA), |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| MERCK KGAA | Germany | Public Company | Life Science (lab and bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials), |
| NEOGEN CORPORATION | United States | Public Company | Food Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals, |
| QIAGEN | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB and transplant/viral load assays),Oncology and sexual/reproductive health assays, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Life Science instruments and systems,Life Science reagents and consumables,Clinical diagnostic test systems and informatics, |
| BRUKER | United States | Public Company | NMR/EPR and Preclinical Imaging (BSI BioSpin),Mass Spectrometry, Molecular Diagnostics, and CALID Solutions,X-ray, AFM, and Nano-Analysis (BSI Nano), |
| SHIMADZU CORPORATION | Japan | Public Company | Analytical and Measuring Instruments,Medical Systems,Industrial and Vacuum Machinery, |
| CHARLES RIVER LABORATORIES | United States | Public Company | Research Models and Services,Discovery and Safety Assessment,Manufacturing Solutions, |
| EUROFINS SCIENTIFIC | Luxembourg | Public Company | Food and Feed Testing, Assurance and Certification,Environment Testing (water, air, soil, waste, maritime),Biopharma Services and Clinical Diagnostics, |
| IDEXX | United States | Public Company | Companion Animal Group (in-clinic analyzers, SNAP tests, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy plus Human Diagnostics, |
bioMérieux is a French public company founded in 1963 that employs 14,894 people. The company operates in the life sciences and diagnostics sector.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a major player in the life sciences and laboratory services industry.
Merck KGaA is a German public company with roots dating back to 1668 and currently employs 59,077 people. The company operates across pharmaceuticals, life sciences, and specialty chemicals.
Neogen Corporation is a United States-based public company founded in 1981 with 2,974 employees. The company provides food and animal safety solutions.
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company specializes in molecular diagnostics and life sciences technologies.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.
Bruker is a United States-based public company founded in 1960 with 11,085 employees. The company develops scientific instruments and analytical solutions for research and diagnostics.
Shimadzu Corporation is a Japanese public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.
Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services for drug development.
Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.
IDEXX is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostics and software for veterinary and water testing markets.
Canada's microbiology testing market is valued at $297.5 million in 2025 and is expected to reach $368.3 million by 2030.
Canada's microbiology testing market is growing at a compound annual growth rate (CAGR) of 3.7% from 2025 to 2030.
Key drivers include Canada's aging population, rising infectious disease prevalence, healthcare modernization, antimicrobial stewardship initiatives, and laboratory automation investments.
Canada's regulatory oversight by Health Canada and provincial health authorities ensures quality standards and supports market confidence in microbiology testing solutions.
Laboratory automation and digital pathology technologies are accelerating adoption of advanced microbiology testing in Canada, improving efficiency and diagnostic accuracy.
The objective of the study is to analyze the key market dynamics of the microbiology testing sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine segment and subsegment sizes.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
Both the top-down and bottom-up approaches have been used to estimate and validate the size of the small satellite market.
The top-down and bottom-up approaches were used to estimate and validate the total size of the microbiology testing market. These methods were also widely used to estimate the sizes of various market segments. The research methodology used to estimate the market size includes the following:

After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides.
Microbiology testing involves the identification, quantification, and analysis of microorganisms, including bacteria, viruses, fungi, and protozoa, and plays a critical role in ensuring product safety, protecting public health, and preserving environmental integrity. These tests are widely used across pharmaceutical and biotech companies, food and beverage companies, environmental and water testing, cosmetics and personal-care companies, the agriculture and animal feed industry, and academic and research institutes, where they support quality control, regulatory compliance, contamination monitoring, and scientific research activities.
MarketsandMarkets offers the following customizations for this market report.
Full forecast, segment splits, and company analysis for all Microbiology Testing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report